Variables entered | Model A | Model B | Model C | Model D | Model E | Model F |
---|---|---|---|---|---|---|
Male (ref: femalef) | 1.95 (1.18–3.22)** | 2.07 (1.25–3.43)** | 2.16 (1.3–3.59)** | 2.21 (1.33–3.67)** | 1.87 (1.13–3.09)* | 1.9 (1.13–3.18)* |
Age ref: < 50 | ||||||
50 ≤ Age < 60 | 0.76 (0.48–1.22) | 0.82 (0.54–1.24) | 0.86 (0.54–1.39) | 0.89 (0.55–1.44) | 0.80 (0.53–1.21) | 0.75 (0.46–1.2) |
60 ≤ Age < 70 | 0.64 (0.45–0.92)* | 0.91 (0.59–1.4) | 0.66 (0.46–0.95)* | 0.68 (0.47–0.99)* | 0.94 (0.62–1.42) | 0.64 (0.44–0.92)* |
≥70 | 0.72 (0.5–1.03) | 1.17 (0.72–1.89) | 0.74 (0.52–1.07) | 0.75 (0.52–1.09) | 1.09 (0.68–1.76) | 0.66 (0.46–0.96)* |
Stage 4 (ref: 3b) | 2.05 (1.57–2.68)** | 1.83 (1.39–2.42)** | 1.85 (1.4–2.45)** | 1.75 (1.32–2.33)** | 2.13 (1.62-2.82)** | 1.94 (1.47–2.55)** |
Comorbidity | 1.35 (1.04–1.74)* | 1.35 (1.04–1.75)* | 1.39 (1.07–1.8)* | 1.45 (1.11–1.89)** | 1.28 (0.98–1.68) | 1.38 (1.06–1.8)* |
QLQ-C30 | ||||||
PF(ref: ≥ 86.67) | 1.00 | 1.00 | ||||
66.66 > PF ≤ 86.66 | 1.05 (0.74–1.49) | 0.88 (0.6–1.29) | ||||
PF ≤ 66.65 | 1.52 (1.03–2.24)* | 1.24 (0.81–1.88) | ||||
RF(ref: ≥ 100.0) | 1.00 | 1.00 | ||||
66.66 > RF ≤ 99.99 | 1.14 (0.83–1.57) | 1.03 (0.75–1.42) | ||||
RF ≤ 66.65 | 1.26 (0.76–2.07) | 1.36 (0.81–2.28) | ||||
FA | 1.34 (0.84–2.13) | 1.34 (0.8–2.26) | ||||
SL | 1.23 (0.92–1.65) | 1.22 (0.9–1.65) | ||||
AP | 1.1 (0.82–1.48) | 1.08 (0.79–1.47) | ||||
CO | 1.49 (1.14–1.93)** | 1.5 (1.15–1.98)** | ||||
EQ-5D | ||||||
Mobility | 3.03 (1.65–5.56)** | |||||
Selfcare | 0.98 (0.39–2.43) | |||||
Usual activities | 1.76 (1.19–2.61)** | |||||
Pain | 0.97 (0.62–1.53) | |||||
Mood | 0.79 (0.42–1.5) | |||||
FACT-L | ||||||
Pwb (ref: ≥ 23.00) | 1.00 | |||||
15 > Pwb ≤ 22 | 1.24 (0.81–1.91) | |||||
Pwb ≤ 15 | 1.18 (0.83–1.67) | |||||
Fwb (ref: ≥ 20.00) | 1.00 | |||||
13 > Fwb ≤ 19 | 1.24 (0.84–1.84) | |||||
Fwb ≤ 13 | 1.04 (0.74–1.48) | |||||
LCS (ref: ≥ 21.00) | 1.00 | |||||
15 > LCS ≤ 20 | 1.09 (0.76–1.57) | |||||
LCS ≤ 15 | 0.7 (0.51–0.97)* |